Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox A vs Anticholinergics for Urge Urinary Incontinence
NCT01166438Phase 3Completed
- Sponsor
- Pelvic Floor Disorders Network
- Start
- Mar 2010
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in urge urinary incontinence (UUI), overactive bladder syndrome (OAB), sponsored by Pelvic Floor Disorders Network. Started Mar 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
urge urinary incontinence (UUI)overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT01166438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166438.